跳至主要内容
临床试验/NL-OMON42343
NL-OMON42343尚未招募不适用

An observational controlled study on vaginal blood flow and sexual functioning after early stage cervical cancer treatment - Sexuo-physiological functioning after cervical cancer treatment

eids Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Pre-menopausal women who have undergone conventional radical hysterectomy with pelvic lymphadenectomy using the Okabayashi method (RHL-WO) at the AMC for the treatment of early stage cervical cancer (FIGO IA2 * IIA). Women are selected on pre-menopausal status because menopausal status can influence the vaginal bloodflow. Women with a history of cervical cancer can be included if treatment has been completed at least 12 months before. All eligible patients have been treated for FIGO stage IA2-IIA cervical cancer with therapyRHL-WO; have no signs of recurrent or metastatic cervical cancer after 1 year; have not received external beam radiation therapy, intravaginal brachytherapy and/or concomitant chemotherapy; did not have their ovaries removed during surgery; are capable of understanding, reading and writing the Dutch language; are not pregnant; have performance status of WHO 1-2, Karnofsky >60; and are <75 52 years of age. Use of medication and hormonal substitutes is registered.

排除标准

  • Women that receive radiotherapy and/or concomitant chemotherapy; had their ovaries removed during surgery; or are pregnant; are not included.

研究者

相似试验